While 3-FEA has not been formally researched on a similar stage as classic amphetamines, it can be at this time assumed that like other substituted amphetamines with substitutions at identical positions, it almost certainly acts largely to be a triple reuptake inhibitor and/or releaser from the monoamine neurotransmitters serotonin, dopamine, and n